SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer Harboring<i>BRAF</i>G469A Mutation by Inhibiting the MAPK Signaling Pathway

Loading papers...

SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer Harboring<i>BRAF</i>G469A Mutation by Inhibiting the MAPK Signaling Pathway | InnScience